Cetera Investment Advisers’s Checkpoint Therapeutics CKPT Stock Holding History

Cetera Investment Advisers’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-23,413	Closed	-$94.6K	–	4112
2025 Q1	$94.6K	Buy	23,413 +3,176	+16%	+$10.6K	﹤0.01%	3785
2024 Q4	$64.8K	Sell	20,237 -6,133	-23%	-$20.8K	﹤0.01%	3634
2024 Q3	$59.1K	Sell	26,370 -1,346	-5%	-$3.11K	﹤0.01%	3588
2024 Q2	$59.6K	Buy	27,716 +3,359	+14%	+$5.98K	﹤0.01%	3583
2024 Q1	$49.9K	Buy	24,357 +10,010	+70%	+$20K	﹤0.01%	3568
2023 Q4	$32.9K	Sell	14,347 -3,329	-19%	-$7.25K	﹤0.01%	2181
2023 Q3	$30K	Buy	17,676 +2,386	+16%	+$5.42K	﹤0.01%	2144
2023 Q2	$37.8K	Buy	+15,290	New	+$41.8K	﹤0.01%	2135

Cetera Investment Advisers's CKPT Position: Q2 2025 in Review

Cetera Investment Advisers sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 23,413 shares — an estimated $94.6K sold.

Cetera Investment Advisers first reported a position in CKPT in Q2 2023 and held it in 8 quarters. The position peaked at $94.6K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Cetera Investment Advisers reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Cetera Investment Advisers sold 23,413 Checkpoint Therapeutics shares in Q2 2025, an estimated $94.6K.
Cetera Investment Advisers first reported a position in Checkpoint Therapeutics in Q2 2023 and held it in 8 quarters.
Cetera Investment Advisers's Checkpoint Therapeutics position peaked at $94.6K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Cetera Investment Advisers's 13F filing for Q2 2025, filed 8 Aug 2025.